LY 345899)

LY 345899) Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: CAS:10538-99-5
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G.100G
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:LY 345899
CAS:10538-99-5
Purity:98.00% Package:1 mL * 10mM (in DMSO);10 mg;100 mg;200 mg;25 mg;5 mg;50 mg;500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Nextpeptide Inc
Tel: +86-0571-81612335 +8613336028439
Email: sales@nextpeptide.com
Products Intro: Product Name:(2S)-2-(4-(3-Amino-1,9-dioxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl)benzamido)pentanedioic acid
CAS:10538-99-5
Purity:98% Min. Package:5KG;1KG
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:LY-345899
CAS:10538-99-5
Purity:98% Package:5mg Remarks:V4845
Company Name: LEAP CHEM CO., LTD.
Tel: +86-852-30606658
Email: market18@leapchem.com
Products Intro: Product Name:LY-345899
CAS:10538-99-5
Package:1g; 5g; 25g; 1kg; 5kg; 25kg
LY 345899) Basic information
Product Name:LY 345899)
Synonyms:LY 345899);LY-345899 (LY345899;L-Glutamic acid, N-[4-(3-amino-1,2,5,6,6a,7-hexahydro-1,9-dioxoimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl]-;(2S)-2-(4-(3-Amino-1,9-dioxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl)benzamido)pentanedioic acid;inhibit,LY345899,LY-345899,Inhibitor,LY 345899,Methylenetetrahydrofolate Dehydrogenase (MTHFD)
CAS:10538-99-5
MF:C20H21N7O7
MW:471.42
EINECS:
Product Categories:
Mol File:10538-99-5.mol
LY 345899) Structure
LY 345899) Chemical Properties
density 1.82±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO:125.0(Max Conc. mg/mL);265.16(Max Conc. mM)
form A solid
pka3.46±0.10(Predicted)
Safety Information
MSDS Information
LY 345899) Usage And Synthesis
Biological ActivityLY 345899, a folate analog, is also a methylenetetrahydrofolate dehydrogenase (MTHFD1; DC301) and MTHFD2 inhibitor with IC50 values of 96 nM and 663 nM, respectively, and Ki value for MTHFD1 of 18 nM.
in vitro

LY 345899 could suppress the MTHFD enzyme in the cytoplasm and mitochondria.
LY 345899 could disturb the NADPH and redox homeostases and accelerate cell death under oxidative stress, such as hypoxia, or causing in vitro anchorage independence and in vivo impaired tumor growth and metastasis.

in vivo

LY345899 (Intraperitoneal injection; 5-10 mg/kg; 5 d/wk; 4 weeks) shows potent antitumor activity and displays therapeutic activity against CRC in vivo .

< td class="col1 fwb"> Animal Model: < td class="col1 fwb"> Dosage: table>
SW620 or PDX-based BABL/c nude colorectal cancer (CRC) model
5-10 mg/kg
Administration: Intraperitoneal injection; 5-10 mg/kg; 5 d/wk; 4 weeks
Result : Displayed lower cell proliferation indices and higher cell apoptosis. Exhibited no statistically significant weight loss or other signs of acute or delayed toxicity in mice.
target

Ki: 18 nM (MTHFD1); IC50: 96 nM (MTHFD1) and 663 nM (MTHFD2)

LY 345899) Preparation Products And Raw materials
Tag:LY 345899)(10538-99-5) Related Product Information
LY-2940094 LY 456236 [2-[(4-Fluorophenyl)amino]-4-methyl-5-thiazolyl]-3-thienylmethanone 3-AMINO-5-CHLORO-N-CYCLOPROPYL-6-METHOXY-4-METHYLTHIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE LY2955303 LY 334370 HYDROCHLORIDE